
BlackRock
BMEBlackRock Health Sciences Trust Price (BME)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
13,943,973
(0)%Income Statement Summary
Revenue | |
Cost of Revenue | |
Gross Profit | |
Operating Expenses | |
Operating Income | |
Other Expenses | |
Net Income |


Income Statement
BlackRock Health Sciences TrustCurrency: USD
YEAR | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||
Revenue |
0.00
+0% |
0.00
+0% |
0.00
+0% |
-25,970,949.00
+0% |
20,410,615.00
-179% |
24,071,879.00
+18% |
|||||||||||||
Cost of Revenue | |||||||||||||||||||
Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -8,464,140.00 | 0.00 | |||||||||||||
Gross Profit | |||||||||||||||||||
Gross Profit |
0.00
+0% |
0.00
+0% |
0.00
+0% |
-25,970,949.00
+0% |
28,874,755.00
-211% |
24,071,879.00
-17% |
|||||||||||||
Gross Profit Ratio | (0.00%) | (0.00%) | (0.00%) | (1.00%) | (1.41%) | (1.00%) | |||||||||||||
Operating Expenses | |||||||||||||||||||
Research and Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
General and Administrative | 0.00 | 0.00 | 0.00 | 362,164.00 | 299,026.00 | 355,526.00 | |||||||||||||
Selling, General & Admin... | 0.00 | 0.00 | 0.00 | 362,164.00 | 299,026.00 | 355,526.00 | |||||||||||||
Selling & Marketing Exp... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
Depreciation and Amortiz... | 171,860.00 | 206,297.00 | 236,558.00 | 228,485.00 | 11,560,458.00 | 0.00 | |||||||||||||
Other Expenses | 0.00 | 0.00 | 0.00 | -26,333,113.00 | 20,111,589.00 | 23,716,353.00 | |||||||||||||
Total Operating Expenses | 0.00 | 0.00 | 0.00 | -25,970,949.00 | 20,410,615.00 | 24,071,879.00 | |||||||||||||
Cost and Exponses | 0.00 | 0.00 | 0.00 | -25,970,949.00 | 20,410,615.00 | 24,071,879.00 | |||||||||||||
Operating Income | |||||||||||||||||||
Operating Income |
0.00
+0% |
0.00
+0% |
0.00
+0% |
0.00
+0% |
8,464,140.00
+0% |
-46,909,730.00
-654% |
|||||||||||||
Operating Income Ratio | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.41%) | (-1.95%) | |||||||||||||
Other Income and Exp... | |||||||||||||||||||
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
Interest Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 55.00 | 78.00 | |||||||||||||
Total Other Income/Exp... | 0.00 | 0.00 | 0.00 | -26,471,079.00 | 11,552,878.00 | 70,364,517.00 | |||||||||||||
EBITDA | |||||||||||||||||||
EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | 20,024,598.00 | 0.00 | |||||||||||||
EBITDA ratio | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.98%) | (0.00%) | |||||||||||||
Income Before Tax | |||||||||||||||||||
Income Before Tax | 0.00 | 0.00 | 0.00 | -26,471,079.00 | 20,017,018.00 | 23,454,787.00 | |||||||||||||
Income Before Tax Ratio | (0.00%) | (0.00%) | (0.00%) | (1.02%) | (0.98%) | (0.97%) | |||||||||||||
Income Tax Expense | |||||||||||||||||||
Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
Net Income | |||||||||||||||||||
Net Income | 0.00
+0% |
0.00
+0% |
0.00
+0% |
-26,471,079.00
+0% |
20,017,018.00
-176% |
23,454,787.00
+17% |
|||||||||||||
Net Income Ratio | (0.00%) | (0.00%) | (0.00%) | (1.02%) | (0.98%) | (0.97%) | |||||||||||||
Earning Per Share | |||||||||||||||||||
Basic EPS | 1.45 | 11.63 | -2.55 | -2.10 | 1.44 | 1.68 | |||||||||||||
Diluted EPS | 1.45 | 11.63 | -2.55 | -2.10 | 1.44 | 1.68 | |||||||||||||
Share Outstanding | |||||||||||||||||||
Basic Share Outstanding | 78,089,172.00 | 112,695,132.00 | 112,880,936.00 | 12,605,276.00 | 13,943,973.00 | 13,943,973.00 | |||||||||||||
Diluted Share Outstanding | 78,089,172.00 | 112,695,132.00 | 112,880,936.00 | 12,605,276.00 | 13,943,973.00 | 13,943,973.00 |